Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Manhattan Bridge Capital | LOAN | Nov 22, 2024 | 5.33 | +1.52 |
Manitex International | MNTX | Nov 22, 2024 | 5.74 | +0.17 |
Manitowoc | MTW | Nov 22, 2024 | 10.81 | +2.27 |
Mannatech | MTEX | Nov 22, 2024 | 8.40 | 0.00 |
MannKind | MNKD | Nov 22, 2024 | 6.84 | -0.87 |
ManpowerGroup | MAN | Nov 22, 2024 | 62.48 | +2.76 |
Manulife Financial | MFC | Nov 22, 2024 | 32.47 | -0.64 |
Maplebear | CART | Nov 22, 2024 | 43.22 | -0.07 |
Marathon Digital | MARA | Nov 22, 2024 | 26.03 | +7.65 |
Marathon Oil | MRO | Nov 22, 2024 | 28.55 | 0.00 |
Marathon Petroleum | MPC | Nov 22, 2024 | 158.48 | -0.51 |
Maravai LifeSciences A | MRVI | Nov 22, 2024 | 5.22 | +5.24 |
Marblegate Acquisition A | GATE | Nov 22, 2024 | 11.13 | 0.00 |
Marchex B | MCHX | Nov 22, 2024 | 1.65 | -2.94 |
Marcus | MCS | Nov 22, 2024 | 22.03 | +0.96 |
Marcus & Millichap | MMI | Nov 22, 2024 | 41.20 | +1.53 |
Marex Group | MRX | Nov 22, 2024 | 29.18 | -1.65 |
Marin Software | MRIN | Nov 22, 2024 | 2.11 | +6.50 |
Marine Petroleum Trust U | MARPS | Nov 22, 2024 | 4.06 | +1.54 |
Marine Products | MPX | Nov 22, 2024 | 9.98 | +1.42 |
MarineMax | HZO | Nov 22, 2024 | 30.56 | +2.86 |
Marinus Pharmaceuticals | MRNS | Nov 22, 2024 | 0.33 | +0.84 |
Maris-Tech | MTEK | Nov 22, 2024 | 1.71 | -2.29 |
Markel | MKL | Nov 22, 2024 | 1 750.00 | +1.84 |
Marker Therapeutics | MRKR | Nov 22, 2024 | 3.10 | +5.02 |
Market Vectors Bdc Income ETF | BIZD | Nov 22, 2024 | 16.67 | +1.15 |
Market Vectors Investment Grade | FLTR | Nov 22, 2024 | 25.50 | +0.04 |
Market Vectors Israel ETF | ISRA | Nov 22, 2024 | 42.25 | +0.32 |
Market Vectors Preferred Securi | PFXF | Nov 22, 2024 | 18.02 | +0.17 |
MarketAxess | MKTX | Nov 22, 2024 | 260.35 | +0.02 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.